IXICO plc
- Biotech or pharma, animal health
- CMO, CRO
- Diagnostics
- Digital health
- Medical device or technology
- Other products or services
- Other R&D services
- IT, information
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
The IXICO Platform deploys the very latest disease-specific algorithms to create reliable clinical data and precision insights that help accelerate R&D decision making, de-risk clinical research and maximise the potential of drug development programmes.
IXICO is no ordinary iCRO. By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) expertly managing and analysing neurological clinical trials in diseases such as Alzheimer’s, Huntington’s and Parkinson’s, and establishing market leadership tackling the most complex biomarker questions in rare neurodegenerative conditions.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}